Disclosure of Adverse Events in Pediatrics

,

    Pediatrics
    |December 13, 2016
    PubMed

    Insights

    Preventable adverse events (AEs) harm patients, but disclosure is hindered by liability fears. Legal reforms, better communication, and disclosure programs can improve reporting of AEs.

    Area of Science:

    • Medical Ethics
    • Patient Safety
    • Health Law

    Background:

    • Preventable adverse events (AEs) remain a significant concern in healthcare, leading to patient, family, and provider harm.
    • Pediatricians recognize an ethical duty to disclose AEs and medical errors to patients and families.
    • Fear of legal liability is a major barrier to the open disclosure of AEs.

    Purpose of the Study:

    • To explore the ethical obligation and practical barriers to disclosing preventable adverse events (AEs) in pediatrics.
    • To identify strategies for improving the quality and frequency of AE disclosure communications.

    Main Methods:

    • Literature review on patient safety, medical ethics, and disclosure policies.
    • Analysis of legal and communication barriers impacting AE reporting.
    • Examination of proposed solutions including legal system changes and communication training.

    Main Results:

    • Ethical imperatives for disclosure are widely accepted by pediatricians.
    • Legal concerns, particularly liability, significantly impede disclosure practices.
    • Effective disclosure requires a multi-faceted approach.

    Conclusions:

    • Improving AE disclosure necessitates addressing legal barriers and enhancing communication skills.
    • Development of robust disclosure policies and programs is crucial for patient safety.
    • Systemic changes in the legal and communication frameworks can foster more transparent reporting of adverse events.

    Related Concept Videos

    Pharmacovigilance01:19

    Pharmacovigilance

    Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
    This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
    In some cases, there...
    1.9K
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    411
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    345
    Pharmaceutical Poisoning: Potential Scenarios01:26

    Pharmaceutical Poisoning: Potential Scenarios

    Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
    53
    Types of Reports II: Incident or Occurrence Report01:21

    Types of Reports II: Incident or Occurrence Report

    An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
    Purposes:
    In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
    1.3K
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    605